Alleles A and B of non-structural protein 1 of avian influenza A viruses differentially inhibit beta interferon production in human and mink lung cells

J Gen Virol. 2011 Sep;92(Pt 9):2111-2121. doi: 10.1099/vir.0.031716-0. Epub 2011 Jun 1.

Abstract

Non-structural protein 1 (NS1) counteracts the production of host type I interferons (IFN-α/β) for the efficient replication and pathogenicity of influenza A viruses. Here, we reveal another dimension of the NS1 protein of avian influenza A viruses in suppressing IFN-β production in cultured cell lines. We found that allele A NS1 proteins of H6N8 and H4N6 have a strong capacity to inhibit the activation of IFN-β production, compared with allele B from corresponding subtypes, as measured by IFN stimulatory response element (ISRE) promoter activation, IFN-β mRNA transcription and IFN-β protein expression. Furthermore, the ability to suppress IFN-β promoter activation was mapped to the C-terminal effector domain (ED), while the RNA-binding domain (RBD) alone was unable to suppress IFN-β promoter activation. Chimeric studies indicated that when the RBD of allele A was fused to the ED of allele B, it was a strong inhibitor of IFN-β promoter activity. This shows that well-matched ED and RBD are crucial for the function of the NS1 protein and that the RBD could be one possible cause for this differential IFN-β inhibition. Notably, mutagenesis studies indicated that the F103Y and Y103F substitutions in alleles A and B, respectively, do not influence the ISRE promoter activation. Apart from dsRNA signalling, differences were observed in the expression pattern of NS1 in transfected human and mink lung cells. This study therefore expands the versatile nature of the NS1 protein in inhibiting IFN responses at multiple levels, by demonstrating for the first time that it occurs in a manner dependent on allele type.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Animals
  • Cell Line
  • Epithelial Cells / immunology*
  • Epithelial Cells / virology*
  • Humans
  • Influenza A virus / genetics
  • Influenza A virus / immunology*
  • Influenza A virus / pathogenicity
  • Interferon-beta / antagonists & inhibitors*
  • Interferon-beta / biosynthesis
  • Lung / immunology
  • Lung / virology
  • Mink
  • Mutagenesis, Site-Directed
  • Mutant Proteins / genetics
  • Mutant Proteins / immunology
  • Mutant Proteins / metabolism
  • Recombinant Proteins / genetics
  • Recombinant Proteins / immunology
  • Recombinant Proteins / metabolism
  • Recombination, Genetic
  • Viral Nonstructural Proteins / genetics
  • Viral Nonstructural Proteins / immunology*
  • Viral Nonstructural Proteins / metabolism
  • Virulence Factors / genetics
  • Virulence Factors / immunology*
  • Virulence Factors / metabolism

Substances

  • INS1 protein, influenza virus
  • Mutant Proteins
  • Recombinant Proteins
  • Viral Nonstructural Proteins
  • Virulence Factors
  • Interferon-beta